This study demonstrated that G9a/Ehmt2 and GLP/Ehmt1 expression levels were higher in NB tumors of the St4 INSS stage and MYCN-amplified tumors, which are characteristic of a poorer prognosis. The gene discussed is MYCN; the disease is neuroblastoma.